Atogepant

So in the UK, we have had the organisation that says whether or not GPs are able to prescribe these things is called NICETA, National Institute for Clinical Excellence.

And we have two available, Remedipant and Atogepant, that can be used for the acute treatment of migraine.

And they are very good from the point of view of cardiovascular risk.

They seem to be safer.

If the Pharma Closeout is how you close out your day, follow the show on Spotify or Apple Podcasts.

AbbVie reported positive phase three results for oral atogepant, sold as Qulipta for adult migraine prevention.

Luna tested a short course around menstruation when these patients experience a predictable window of migraine attacks.

Participants took it for seven days, beginning three days before menstruation over three cycles.